A novel rituximab administration protocol to minimize infusion-related adverse reactions in patients with B-cell lymphoma.
Int J Clin Pharm
; 44(2): 366-373, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-34894347
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
Drug-Related Side Effects and Adverse Reactions
/
Antineoplastic Agents
Type of study:
Etiology_studies
/
Guideline
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Int J Clin Pharm
Year:
2022
Document type:
Article
Affiliation country:
Japan